Skip to content
★ Sign in to follow
TD

Thibaut du Fayet

CEO
Chief Executive Officer
Phaxiam Therapeutics
Total declarations
1
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 04 Jul 2023 for Phaxiam Therapeutics.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

No signal scores available.

Thibaut du Fayet: trading record in brief

Our data holds just one disclosure by Thibaut du Fayet, dated 4 July 2023, reporting a transaction in Phaxiam Therapeutics. Further filings will be added here. This summary is built from AMF disclosures alone and does not predict where the share price will go.

Companies and markets linked to Thibaut du Fayet

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations1 total
  • ●
    Chief Executive OfficerExecutivesPhaxiam Therapeutics
    0AMF
    54,862 shares@ €0.61100.0% of flowActionHors plateforme de négociationISIN FR00114711352023DD917744

1 of 1 declaration